| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,688 |
6,866 |
$1.20M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
167 |
162 |
$339K |
| 80053 |
Comprehensive metabolic panel |
4,345 |
3,857 |
$252K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
617 |
537 |
$175K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,235 |
3,870 |
$134K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
274 |
162 |
$115K |
| 36415 |
Collection of venous blood by venipuncture |
2,422 |
2,143 |
$45K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
73 |
65 |
$27K |
| 84443 |
Thyroid stimulating hormone (TSH) |
528 |
483 |
$27K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
472 |
458 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
270 |
251 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
138 |
137 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
217 |
199 |
$8K |
| 85004 |
|
521 |
342 |
$7K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
498 |
447 |
$5K |
| 86140 |
|
248 |
224 |
$5K |
| 80061 |
Lipid panel |
80 |
78 |
$5K |
| 87400 |
|
143 |
140 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
74 |
72 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
167 |
162 |
$3K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
23 |
21 |
$3K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
17 |
16 |
$3K |
| 87430 |
|
108 |
105 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
29 |
27 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
107 |
100 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
12 |
12 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
87 |
82 |
$1K |
| J2300 |
Injection, nalbuphine hydrochloride, per 10 mg |
67 |
67 |
$1K |
| 0011A |
|
51 |
49 |
$963.88 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
15 |
13 |
$869.60 |
| 82607 |
|
12 |
12 |
$675.48 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
38 |
38 |
$615.68 |
| 81001 |
|
26 |
25 |
$566.50 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
13 |
12 |
$488.63 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
19 |
13 |
$474.84 |
| 0012A |
|
23 |
23 |
$413.42 |
| 86756 |
|
13 |
13 |
$303.45 |
| 81003 |
|
17 |
14 |
$281.82 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
12 |
12 |
$260.09 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
14 |
13 |
$244.21 |
| 80306 |
|
14 |
12 |
$230.45 |
| J3490 |
Unclassified drugs |
12 |
12 |
$183.70 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
12 |
12 |
$119.87 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13 |
12 |
$108.25 |